Compugen (CGEN) director Holcomb reports shares, options and RSUs

Rhea-AI Filing Summary

Compugen Ltd director Michele Holcomb filed an initial ownership report showing equity awards tied to her service. She holds 15,000 Ordinary Shares directly and a share option for 20,000 Ordinary Shares at an exercise price of $1.76 per share, expiring on February 11, 2036. The option vests 25% on April 1, 2027, with the remainder vesting in 12 equal quarterly installments, and related RSUs follow the same vesting schedule, all subject to her continued service to Compugen.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Holcomb Michele

Role Director

Type	Security	Shares	Price	Value
holding	Share Option (right to buy)	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Share Option (right to buy) — 20,000 shares (Direct); Ordinary Shares — 15,000 shares (Direct)

Footnotes (1)

1. Represents restricted stock units ("RSUs") which vest 25% on April 1, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. This option vests 25% on April 1, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Holcomb Michele

(Last) (First) (Middle)

C/O COMPUGEN LTD.

26 HAROKMIM STREET

(Street)

HOLON 5885849

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
COMPUGEN LTD [ CGEN ]

3a. Foreign Trading Symbol
[CGEN]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	15,000(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option (right to buy)	(2)	02/11/2036	Ordinary Shares	20,000	$1.76	D

Explanation of Responses:

1. Represents restricted stock units ("RSUs") which vest 25% on April 1, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.

2. This option vests 25% on April 1, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.

	/s/ Michele Holcomb	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Michele Holcomb’s Form 3 filing show for Compugen (CGEN)?

The Form 3 shows director Michele Holcomb’s initial equity holdings in Compugen. She reports 15,000 Ordinary Shares and options over 20,000 shares at $1.76, plus RSUs that vest over time, all tied to continued service.

How many Compugen (CGEN) shares does Michele Holcomb report owning?

Michele Holcomb reports 15,000 Ordinary Shares of Compugen held directly. This reflects her beneficial ownership position in the common equity at the time of the Form 3 filing, separate from her options and restricted stock units that vest later.

What stock options does Michele Holcomb hold in Compugen (CGEN)?

She holds a share option for 20,000 Ordinary Shares with an exercise price of $1.76 per share, expiring on February 11, 2036. The option vests 25% on April 1, 2027, then in 12 equal quarterly installments, contingent on continued service.

How do Michele Holcomb’s RSUs in Compugen (CGEN) vest?

Her restricted stock units (RSUs) vest 25% on April 1, 2027, with the remaining 75% vesting in 12 equal quarterly installments. Vesting is conditioned on her continued service to Compugen throughout the vesting period, as stated in the footnotes.

Does Michele Holcomb’s Form 3 show recent buying or selling of Compugen (CGEN) stock?

The Form 3 reflects holdings and equity awards, not explicit recent purchases or sales. Transactions are coded as holdings, with no buy or sell codes reported, indicating this is an initial ownership statement rather than a trading activity report.